|
2025
|
Invention
|
Drug-in-capsule formulations of thromboxane receptor antagonists.
The invention provides formula... |
|
|
Invention
|
Drug-in-capsule formulations of thromboxane receptor antagonists. The invention provides formulat... |
|
2021
|
Invention
|
Thromboxane receptor antagonist formulations.
The present invention provides formulations that e... |
|
|
Invention
|
Thromboxane receptor antagonist formulations. 2222 receptor ligands, are implicated. The formulat... |
|
2019
|
Invention
|
Thromboxane receptor antagonists. 2 and of all other agents that act as incidental ligands of TP ... |
|
2018
|
Invention
|
Thromboxane receptor antagonists. 2α), play a role. Compounds of the invention preferably include... |
|
2017
|
Invention
|
Methods and compounds for treating proliferative disorders and viral infections.
The invention g... |
|
|
Invention
|
Thromboxane receptor antagonists. The invention generally relates to compounds that function as T... |
|
2013
|
Invention
|
Methods and compounds for treating proliferative disorders and viral infections. The invention ge... |
